Corcept Therapeutics
The Vice President, Neurology leads the Neurology Clinical Development team and portfolio at Corcept, overseeing the planning, management, and execution of clinical development and lifecycle management programs. This role involves steering the direction of the neurology portfolio, designing clinical studies, and collaborating with senior management, operations, and commercial teams to bring treatments to patients. The position requires strong leadership, clinical development expertise, and the ability to engage with key opinion leaders and regulatory bodies.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
1998
Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT
8 hours ago
REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026
1 day ago
Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements
7 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Corcept Therapeutics.
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com
12 hours ago
Senior Medical Director, Clinical Development, Neurology
lifelancer
Executive Medical Director, Clinical Development
Immunovant, Inc.
Medical Director, Clinical Research Neuromuscular
Cytokinetics
Associate Director, Clinical Development - Neurology
ionis
Development Scientific Director, Neurology (Early Development)
Sanofi
Global Project Head, Neurology Development
Sanofi